ProfileGDS4459 / ENSG00000078304
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 89% 88% 82% 92% 86% 85% 83% 84% 83% 84% 88% 83% 83% 89% 83% 87% 83% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.9689
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.7588
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.4282
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 47.2992
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.8286
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.6485
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.5283
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.6284
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.5783
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.584
GSM623474group B, liver allograft wedge biopsie placebo treatment 17.1288
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.5183
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.4383
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.9789
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.5783
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.7687
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.383